thursady killer, page-25

Stock rock you may have to wait a little longer....

Here is the full email reply from Dennis....

You should feel free to communicate my response last night as you see fit. The same goes for this email.

Solagran has absolutely nothing to hide in this matter – although it is true that no one from Solagran here in Australia was aware of the test site in Hungary until a couple of shareholders brought it to our attention.

Personal contacts of the Directors have been very helpful with Solagran’s activities – both in Eastern Europe and in Australia. I had a lengthy exchange with David Szultanov in Budapest late last night. He was most concerned that his attempts to help us to improve the functionality of the Solagran web site for the benefit of shareholders (and in the context of our plan to put up the Russian and German language versions of our site in the very near future) had created problems for us here in Australia. The Russian and German sites are almost ready to go, and as David pointed out, it was an honest mistake on the part of his web developers who provided a demo to Vagif Soultanov and Charles Pellegrino in Budapest last weekend.

David is a successful entrepreneur in Hungary. He is also a Solagran shareholder, has introduced a number of other shareholders to the company, and has created quite a few opportunities for the company in central Europe through his excellent client base and contacts.

I trust the matter can now be put to rest. We would be more than happy to take questions on this at the forthcoming EGM – should it still be an issue in the mind of any shareholder. However I believe that there will be more important issues to discuss at the EGM.

To your other point, yes this is a big week for Solagran. There will be three presentations to the Gastro 2007 conference this week that are directly related to Solagran. The conference starts with informal sessions Wednesday afternoon. The formal sessions are Thursday and Friday. I am trying to get clarification in relation to exactly when Elena Laptiva’s presentation on Ropren’s liver regeneration action animal models (liver resection) and Vagif’s presentation on the Ropren clinical trials results will happen. We will advise the market once we are 100 percent certain on timing so that we co-ordinate the release of information.

Kind regards
Denis Kilroy

So tonite will be a bit of boring dribbling and then the next two days will be the big ones....well that's what it sounds like....tomorrow or Friday we may know more...

...and by Monday we should have all 3 results bagged up and presented at the latest.

Bummer, I don't know if I can wait that long.....POP!